P-glycoprotein (ABCB1) - weak dipolar interactions provide the key to understanding allocrite recognition, binding, and transport
暂无分享,去创建一个
[1] K. Locher,et al. Discovery and Characterization of Potent Dual P-Glycoprotein and CYP3A4 Inhibitors: Design, Synthesis, Cryo-EM Analysis, and Biological Evaluations. , 2021, Journal of medicinal chemistry.
[2] K. Linton,et al. ABCB1 Does Not Require the Side-Chain Hydrogen-Bond Donors Gln347, Gln725, Gln990 to Confer Cellular Resistance to the Anticancer Drug Taxol , 2021, International journal of molecular sciences.
[3] Amanda F. Clouser,et al. Cholesterol Asymmetrically Modulates the Conformational Ensemble of the Nucleotide-Binding Domains of P-Glycoprotein in Lipid Nanodiscs. , 2020, Biochemistry.
[4] A. Seelig. P-Glycoprotein: One Mechanism, Many Tasks and the Consequences for Pharmacotherapy of Cancers , 2020, Frontiers in Oncology.
[5] Oded Lewinson,et al. Structures of ABC transporters: handle with care , 2020, FEBS letters.
[6] E. Tajkhorshid,et al. Structural and functional diversity calls for a new classification of ABC transporters , 2020, FEBS letters.
[7] R. Tampé,et al. Structural and Mechanistic Principles of ABC Transporters. , 2020, Annual review of biochemistry.
[8] S. Genovese,et al. Citrus auraptene induces drug efflux transporter P-glycoprotein expression in human intestinal cells. , 2020, Food & function.
[9] K. Levental,et al. Plasma membranes are asymmetric in lipid unsaturation, packing, and protein shape , 2020, Nature Chemical Biology.
[10] M. Gottesman,et al. Multidrug transporters: recent insights from cryo-electron microscopy-derived atomic structures and animal models , 2020, F1000Research.
[11] G. Hummer,et al. Structure of Outward-Facing PglK and Molecular Dynamics of Lipid-Linked Oligosaccharide Recognition and Translocation. , 2019, Structure.
[12] M. Gottesman,et al. Revisiting the role of ABC transporters in multidrug-resistant cancer , 2018, Nature Reviews Cancer.
[13] S. Ambudkar,et al. Effects of a detergent micelle environment on P-glycoprotein (ABCB1)-ligand interactions , 2017, The Journal of Biological Chemistry.
[14] S. Bernèche,et al. Unidirectional Transport Mechanism in an ATP Dependent Exporter , 2017, ACS central science.
[15] A. Seelig,et al. How Phosphorylation and ATPase Activity Regulate Anion Flux though the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)* , 2016, The Journal of Biological Chemistry.
[16] G. Szakács,et al. A single active catalytic site is sufficient to promote transport in P-glycoprotein , 2016, Scientific Reports.
[17] S. Ambudkar,et al. Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein. , 2016, Biochemical pharmacology.
[18] A. Seelig,et al. Predicting Activators and Inhibitors of the Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1) Based on Mechanistic Considerations. , 2015, Molecular pharmaceutics.
[19] S. Bernèche,et al. Allocrite Sensing and Binding by the Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1). , 2015, Biochemistry.
[20] Hiroyuki Noji,et al. Diversity in ATP concentrations in a single bacterial cell population revealed by quantitative single-cell imaging , 2014, Scientific Reports.
[21] R. Lill,et al. Crystal Structures of Nucleotide-Free and Glutathione-Bound Mitochondrial ABC Transporter Atm1 , 2014, Science.
[22] Stephen G Aller,et al. Refined structures of mouse P-glycoprotein , 2013, Protein science : a publication of the Protein Society.
[23] M. Geisler,et al. Plant ABC Transporters , 2014, Signaling and Communication in Plants.
[24] D. Hwang. Cation-π Interaction , 2013 .
[25] M. Battegay,et al. The brain entry of HIV-1 protease inhibitors is facilitated when used in combination. , 2013, Molecular pharmaceutics.
[26] R. Dawson,et al. Sav1866 from Staphylococcus aureus and P-glycoprotein: similarities and differences in ATPase activity assessed with detergents as allocrites. , 2013, Biochemistry.
[27] Tiago M. Ferreira,et al. Cholesterol and POPC segmental order parameters in lipid membranes: solid state 1H-13C NMR and MD simulation studies. , 2013, Physical chemistry chemical physics : PCCP.
[28] F. Sharom,et al. Lipid bilayer properties control membrane partitioning, binding, and transport of p-glycoprotein substrates. , 2013, Biochemistry.
[29] A. Seelig,et al. P-glycoprotein-ATPase modulation: the molecular mechanisms. , 2012, Biophysical journal.
[30] J. Killian,et al. Probing the lipid-protein interface using model transmembrane peptides with a covalently linked acyl chain. , 2011, Biophysical journal.
[31] I. Holland,et al. ABC transporters, mechanisms and biology: an overview. , 2011, Essays in biochemistry.
[32] G. Szakács,et al. The controversial role of ABC transporters in clinical oncology. , 2011, Essays in biochemistry.
[33] A. Seelig,et al. Exploring the P-glycoprotein binding cavity with polyoxyethylene alkyl ethers. , 2010, Biophysical journal.
[34] Shih-Chung Huang,et al. Neurokinin-1 receptor antagonists: a comprehensive patent survey , 2010, Expert opinion on therapeutic patents.
[35] J. Seelig,et al. Lipid and peptide dynamics in membranes upon insertion of n-alkyl-beta-D-glucopyranosides. , 2010, Biophysical journal.
[36] A. Seelig,et al. P-glycoprotein substrate transport assessed by comparing cellular and vesicular ATPase activity. , 2010, Biochimica et biophysica acta.
[37] Anna Seelig,et al. Detergents as intrinsic P-glycoprotein substrates and inhibitors. , 2009, Biochimica et biophysica acta.
[38] Ulf Norinder,et al. Identification of Novel Specific and General Inhibitors of the Three Major Human ATP-Binding Cassette Transporters P-gp, BCRP and MRP2 Among Registered Drugs , 2009, Pharmaceutical Research.
[39] Yue Weng,et al. Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding , 2009, Science.
[40] S. Hell,et al. Direct observation of the nanoscale dynamics of membrane lipids in a living cell , 2009, Nature.
[41] F. Sharom,et al. Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport. , 2008, Biochemistry.
[42] A. Seelig,et al. P-glycoprotein senses its substrates and the lateral membrane packing density: consequences for the catalytic cycle. , 2008, Biochemistry.
[43] H. V. van Veen,et al. Multidrug transport by the ABC transporter Sav1866 from Staphylococcus aureus. , 2008, Biochemistry.
[44] Virgil L. Woods,et al. Modest stabilization by most hydrogen-bonded side-chain interactions in membrane proteins , 2008, Nature.
[45] Jue Chen,et al. Structure, Function, and Evolution of Bacterial ATP-Binding Cassette Systems , 2008, Microbiology and Molecular Biology Reviews.
[46] Geoffrey Chang,et al. Flexibility in the ABC transporter MsbA: Alternating access with a twist , 2007, Proceedings of the National Academy of Sciences.
[47] Anna Seelig,et al. The Role of Size and Charge for Blood–Brain Barrier Permeation of Drugs and Fatty Acids , 2007, Journal of Molecular Neuroscience.
[48] K. Locher,et al. Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP‐PNP , 2007, FEBS letters.
[49] A. Seelig,et al. P-Glycoprotein kinetics measured in plasma membrane vesicles and living cells. , 2007, Biochemistry.
[50] H. Kato,et al. Modulation of drug-stimulated ATPase activity of human MDR1/P-glycoprotein by cholesterol. , 2007, The Biochemical journal.
[51] F. Sharom. Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1). , 2006, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[52] J. Seelig,et al. Interaction of verapamil with lipid membranes and P-glycoprotein: connecting thermodynamics and membrane structure with functional activity. , 2006, Biophysical journal.
[53] Grégori Gerebtzoff,et al. In Silico Prediction of Blood-Brain Barrier Permeation Using the Calculated Molecular Cross-Sectional Area as Main Parameter , 2006, J. Chem. Inf. Model..
[54] R. Dawson,et al. Structure of a bacterial multidrug ABC transporter , 2006, Nature.
[55] M. Detty,et al. Stimulation of P-glycoprotein ATPase by analogues of tetramethylrosamine: coupling of drug binding at the "R" site to the ATP hydrolysis transition state. , 2006, Biochemistry.
[56] H. Omote,et al. Interaction of transported drugs with the lipid bilayer and P-glycoprotein through a solvation exchange mechanism. , 2006, Biophysical journal.
[57] Anna Seelig,et al. Quantification and characterization of P-glycoprotein-substrate interactions. , 2006, Biochemistry.
[58] R. Himes,et al. Single-site chemical modification at C10 of the baccatin III core of paclitaxel and Taxol C reduces P-glycoprotein interactions in bovine brain microvessel endothelial cells. , 2006, Bioorganic & medicinal chemistry letters.
[59] D. Rigal,et al. Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells. , 2005, Biochemistry.
[60] Y. Kimura,et al. Local dielectric properties around polar region of lipid bilayer membranes , 2005, The Journal of Membrane Biology.
[61] K. Linton,et al. The ATP switch model for ABC transporters , 2004, Nature Structural &Molecular Biology.
[62] I. V. Polozov,et al. Liquid domains in vesicles investigated by NMR and fluorescence microscopy. , 2004, Biophysical journal.
[63] I. Arkin,et al. Experimental Measurement of the Strength of a Cα−H···O Bond in a Lipid Bilayer , 2004 .
[64] J. Seelig,et al. Membrane perturbation by the lipopeptide surfactin and detergents as studied by deuterium NMR , 2004 .
[65] H. Omote,et al. Transition State Analysis of the Coupling of Drug Transport to ATP Hydrolysis by P-glycoprotein* , 2003, Journal of Biological Chemistry.
[66] A. Kabanov,et al. An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[67] F. Sharom,et al. Stoichiometry and affinity of nucleotide binding to P-glycoprotein during the catalytic cycle. , 2003, Biochemistry.
[68] F. Ataullakhanov,et al. What Determines the Intracellular ATP Concentration , 2002, Bioscience reports.
[69] H. Omote,et al. A Novel Electron Paramagnetic Resonance Approach to Determine the Mechanism of Drug Transport by P-glycoprotein* , 2002, The Journal of Biological Chemistry.
[70] G. Fink,et al. Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration , 2002, Nature.
[71] A. Seelig,et al. Real-time monitoring of P-glycoprotein activation in living cells. , 2002, Biochemistry.
[72] J. Seelig,et al. Interactions of cyclosporines with lipid membranes as studied by solid-state nuclear magnetic resonance spectroscopy and high-sensitivity titration calorimetry. , 2002, Journal of pharmaceutical sciences.
[73] L. Benet,et al. Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4. , 2002, The Journal of pharmacology and experimental therapeutics.
[74] M. Gottesman,et al. Overview: ABC Transporters and Human Disease , 2001, Journal of bioenergetics and biomembranes.
[75] C. Higgins,et al. The importance of cholesterol in maintenance of P-glycoprotein activity and its membrane perturbing influence , 2001, European Biophysics Journal.
[76] F. Sharom,et al. Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter. , 2001, Biochemistry.
[77] F. Sharom,et al. Exploring the structure and function of the P-glycoprotein multidrug transporter using fluorescence spectroscopic tools. , 2001, Seminars in cell & developmental biology.
[78] A. Rzhetsky,et al. The human ATP-binding cassette (ABC) transporter superfamily. , 2001, Genome research.
[79] A. Holzenburg,et al. The structure of the multidrug resistance protein 1 ( MRP 1 / ABCC 1 ) : crystallization and single-particle analysis * , 2001 .
[80] Z. Sauna,et al. The Mechanism of Action of Multidrug-Resistance-Linked P-Glycoprotein , 2001, Journal of bioenergetics and biomembranes.
[81] F. Sharom,et al. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter. , 1999, Biochemistry.
[82] V. Ling,et al. Stoichiometry of coupling of rhodamine 123 transport to ATP hydrolysis by P-glycoprotein. , 1998, European journal of biochemistry.
[83] WD Stein. Kinetics of the P‐glycoprotein, the multidrug transporter , 1998, Experimental physiology.
[84] A. Seelig. How does P-glycoprotein recognize its substrates? , 1998, International journal of clinical pharmacology and therapeutics.
[85] A. Seelig. A general pattern for substrate recognition by P-glycoprotein. , 1998, European journal of biochemistry.
[86] C. Higgins,et al. The functional purification of P-glycoprotein is dependent on maintenance of a lipid-protein interface. , 1997, Biochimica et biophysica acta.
[87] T. Litman,et al. Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity. , 1997, Biochimica et biophysica acta.
[88] T. Litman,et al. Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity. , 1997, Biochimica et biophysica acta.
[89] T. Litman,et al. ATPase activity of P-glycoprotein related to emergence of drug resistance in Ehrlich ascites tumor cell lines. , 1997, Biochimica et biophysica acta.
[90] S. Ambudkar,et al. Relation Between the Turnover Number for Vinblastine Transport and for Vinblastine-stimulated ATP Hydrolysis by Human P-glycoprotein* , 1997, The Journal of Biological Chemistry.
[91] M. Wenk,et al. Octyl-beta-D-glucopyranoside partitioning into lipid bilayers: thermodynamics of binding and structural changes of the bilayer. , 1997, Biophysical journal.
[92] N. Ben-Tal,et al. Free Energy of Amide Hydrogen Bond Formation in Vacuum, in Water, and in Liquid Alkane Solution , 1997 .
[93] A. Seelig,et al. Binding of substance P agonists to lipid membranes and to the neurokinin-1 receptor. , 1996, Biochemistry.
[94] Y. Assaraf,et al. Functional Reconstitution of P-glycoprotein Reveals an Apparent Near Stoichiometric Drug Transport to ATP Hydrolysis (*) , 1996, The Journal of Biological Chemistry.
[95] M. Wenk,et al. Paclitaxel partitioning into lipid bilayers. , 1996, Journal of pharmaceutical sciences.
[96] A. E. Senior,et al. The catalytic cycle of P‐glycoprotein , 1995, FEBS letters.
[97] Y. Assaraf,et al. Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability. , 1995, European journal of biochemistry.
[98] M. Gottesman,et al. Interaction of bioactive hydrophobic peptides with the human multidrug transporter , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[99] A. E. Senior,et al. Characterization of the ATPase activity of purified Chinese hamster P-glycoprotein. , 1994, Biochemistry.
[100] L. Becucci,et al. The intrinsic pKa values for phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine in monolayers deposited on mercury electrodes. , 1994, Biophysical journal.
[101] I. Pastan,et al. Fluorescent cellular indicators are extruded by the multidrug resistance protein. , 1993, The Journal of biological chemistry.
[102] A. E. Senior,et al. Characterization of the adenosine triphosphatase activity of Chinese hamster P-glycoprotein. , 1993, The Journal of biological chemistry.
[103] F. Sharom,et al. The effects of lipids and detergents on ATPase-active P-glycoprotein. , 1993, Biochimica et biophysica acta.
[104] I. Pastan,et al. Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.
[105] I. Pastan,et al. Characterization of the azidopine and vinblastine binding site of P-glycoprotein. , 1992, The Journal of biological chemistry.
[106] J. W. Parce,et al. The cytosensor microphysiometer: biological applications of silicon technology. , 1992, Science.
[107] I. Pastan,et al. Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[108] F. Sharom,et al. ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. , 1992, Biochimica et biophysica acta.
[109] R. Boucher,et al. Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. , 1992, The Journal of biological chemistry.
[110] M. Gottesman,et al. Is the multidrug transporter a flippase? , 1992, Trends in biochemical sciences.
[111] J. Seelig,et al. Nonclassical hydrophobic effect in membrane binding equilibria. , 1991, Biochemistry.
[112] J. W. Parce,et al. Continuous monitoring of receptor-mediated changes in the metabolic rates of living cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[113] A. Seelig. The use of monolayers for simple and quantitative analysis of lipid-drug interactions exemplified with dibucaine and substance P. , 1990, Cell biology international reports.
[114] I. Pastan,et al. Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells. , 1990, The Journal of biological chemistry.
[115] J. Lankelma,et al. Induction by verapamil of a rapid increase in ATP consumption in multidrug‐resistant tumor cells , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[116] J. Seelig,et al. Structure and dynamics of the phosphatidylcholine and the phosphatidylethanolamine head group in L‐M fibroblasts as studied by deuterium nuclear magnetic resonance. , 1987, The EMBO journal.
[117] I. Pastan,et al. Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[118] J. Seelig,et al. Phospholipid composition and organization of cytochrome c oxidase preparations as determined by 31P-nuclear magnetic resonance. , 1985, Biochimica et biophysica acta.
[119] J. Seelig,et al. Lipid solvation of cytochrome c oxidase. Deuterium, nitrogen-14, and phosphorus-31 nuclear magnetic resonance studies on the phosphocholine head group and on cis-unsaturated fatty acyl chains. , 1983, Biochemistry.
[120] R. Balaban,et al. Stoichiometry and coupling of active transport to oxidative metabolism in epithelial tissues. , 1981, The American journal of physiology.
[121] H. S. Gutowsky,et al. Protein-lipid interactions in biological and model membrane systems. Deuterium NMR of Acholeplasma laidlawii B, Escherichia coli, and cytochrome oxidase systems containing specifically deuterated lipids. , 1981, The Journal of biological chemistry.
[122] J. Seelig,et al. Lipid conformation in model membranes and biological membranes , 1980, Quarterly Reviews of Biophysics.
[123] J. Op den Kamp. Lipid asymmetry in membranes. , 1979, Annual review of biochemistry.
[124] J. Seelig,et al. Lipid-protein interaction in reconstituted cytochrome c oxidase/phospholipid membranes. , 1978, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[125] H. S. Gutowsky,et al. Deuterium nuclear magnetic resonance investigation of the effects of proteins and polypeptides on hydrocarbon chain order in model membrane systems. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[126] D. Levitt,et al. Theoretical calculation of the dielectric constant of a bilayer membrane. , 1977, Biophysical journal.
[127] J. Seelig,et al. Cholesterol-induced rod-like motion of fatty acyl chains in lipid bilayers a deuterium magnetic resonance study. , 1976, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[128] R L Juliano,et al. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.
[129] E. Newsholme,et al. The contents of adenine nucleotides, phosphagens and some glycolytic intermediates in resting muscles from vertebrates and invertebrates. , 1975, The Biochemical journal.
[130] G. Vanderkooi,et al. Evidence for boundary lipid in membranes. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[131] R. Kornberg,et al. Inside-outside transitions of phospholipids in vesicle membranes. , 1971, Biochemistry.
[132] D E Green,et al. Membrane structure. , 1971, Science.
[133] O. Jardetzky,et al. Simple Allosteric Model for Membrane Pumps , 1966, Nature.